| References |
Top |
| REF 1 |
SPATA2 links CYLD to the TNF- receptor signaling complex and modulates the receptor signaling outcomes. EMBO J. 2016 Sep 1;35(17):1868-84.
|
| REF 2 |
Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression. Cancer Res. 2008 Mar 1;68(5):1462-70.
|
| REF 3 |
ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction. J Biol Chem. 2000 Oct 20;275(42):32747-52.
|
| REF 4 |
Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem. 2006 May 12;281(19):13636-43.
|
| REF 5 |
TAK1 is a central mediator of NOD2 signaling in epidermal cells. J Biol Chem. 2008 Jan 4;283(1):137-44.
|
| REF 6 |
Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J Biol Chem. 1999 Apr 9;274(15):10641-8.
|
| REF 7 |
Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci Signal. 2009 Oct 20;2(93):ra66.
|
| REF 8 |
Molecular determinants of NF-kappaB-inducing kinase action. Mol Cell Biol. 1998 Oct;18(10):5899-907.
|
| REF 9 |
TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell. 2000 Apr;5(4):649-58.
|
